Evidence retrieval, comparison and consequence exploration support study design decisions. Clinical and commercial approvals remain with authorised people.
← Trust Centre
AI governance
Evidence people can review. Decisions people still own.
Tenvia AI uses the customer study to find relevant historical and public evidence, compare it with the proposed design and explain the potential consequence. Sources, assumptions and uncertainty remain available for review.
Assurance position
Each AI use case requires a defined purpose, permitted evidence sources, data boundary, provider terms, testing, monitoring and human review. AI cannot make clinical, regulatory, vendor selection or commercial decisions.
Control register
What buyers need to know.
Statuses distinguish product direction from commitments and evidence for a specific deployment. They are not certification labels.
Control domainCurrent statusPublic position
Outputs are designed to retain source, retrieval date, match basis, assumptions, limitations, confidence and affected decisions.
Evidence is selected against study characteristics such as indication, phase, population and design. Reviewers can inspect the basis for each match.
Authorised people review rationale and retain authority over governed study baselines.
Model providers, retention, training restrictions and data routes are disclosed and configured before production.
Testing for each use case, its limitations, review thresholds and change monitoring are defined for the intended production scope.
Material model, prompt, provider and policy changes require documented review appropriate to their impact.
Prospect FAQ
Direct answers for due diligence.
These answers describe the current public boundary. Contracted controls and evidence must match the actual deployment.
Request deeper evidenceNo. Tenvia presents decision support. Clinical, regulatory, quality and commercial authority remains with appropriately authorised people.
Evidence room preview
Review sensitive assurance under controlled access.
The index below shows the material a diligence review can request. Scope and availability are confirmed item by item before access is granted.
01AI system overviewAvailability confirmed in diligenceControlled
02Evidence source and retrieval modelAvailability confirmed in diligenceControlled
03Approach to matching relevant studiesAvailability confirmed in diligenceControlled
04Intended use and limitations statementAvailability confirmed in diligenceControlled
05Provider and data use scheduleAvailability confirmed in diligenceControlled
06Evaluation summaryAvailability confirmed in diligenceControlled
07Human oversight and change control modelAvailability confirmed in diligenceControlled
Security and diligence
Request the right level of access.
Start with a public product review. Add confidentiality when the discussion includes sensitive study or security information.
How access works
01Explore publiclyReview the product using fixture data. No NDA is required.02Discuss confidentiallyPut a mutual NDA in place before sharing study material.03Review evidenceReceive controlled access to the relevant assurance material.
Access is granted only after Tenvia confirms the request, confidentiality route and available evidence.